4.8 Article

Epigenetic regulation of puberty via Zinc finger protein-mediated transcriptional repression

Journal

NATURE COMMUNICATIONS
Volume 6, Issue -, Pages -

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/ncomms10195

Keywords

-

Funding

  1. NIH [5RO1 HD013254, U54 HD008610]
  2. US National Science Foundation (NSF) [IOS1121691]
  3. Marie Curie International Outgoing Fellowship within the seventh European Community Framework Programme (FP7-PEOPLE-IOF)
  4. NIH Training grant [T32 HD007133, T32 DK00768023]
  5. Division Of Integrative Organismal Systems
  6. Direct For Biological Sciences [1121691] Funding Source: National Science Foundation

Ask authors/readers for more resources

In primates, puberty is unleashed by increased GnRH release from the hypothalamus following an interval of juvenile quiescence. GWAS implicates Zinc finger (ZNF) genes in timing human puberty. Here we show that hypothalamic expression of several ZNFs decreased in agonadal male monkeys in association with the pubertal reactivation of gonadotropin secretion. Expression of two of these ZNFs, GATAD1 and ZNF573, also decreases in peripubertal female monkeys. However, only GATAD1 abundance increases when gonadotropin secretion is suppressed during late infancy. Targeted delivery of GATAD1 or ZNF573 to the rat hypothalamus delays puberty by impairing the transition of a transcriptional network from an immature repressive epigenetic configuration to one of activation. GATAD1 represses transcription of two key puberty-related genes, KISS1 and TAC3, directly, and reduces the activating histone mark H3K4me2 at each promoter via recruitment of histone demethylase KDM1A. We conclude that GATAD1 epitomizes a subset of ZNFs involved in epigenetic repression of primate puberty.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Gastroenterology & Hepatology

Treatment of hepatitis delta and HIV infection

Vicente Soriano, Carmen de Mendoza, Ana Trevino, Jose Manuel Ramos-Rincon, Victor Moreno-Torres, Octavio Corral, Pablo Barreiro

Summary: Hepatitis delta virus (HDV) is a severe form of chronic viral hepatitis that can lead to cirrhosis, liver cancer, and/or transplantation. The recent approval of bulevirtide and the expected availability of lonafarnib have revolutionized HDV therapy. Combination antiviral therapy is envisioned as a potential cure for hepatitis delta. HIV-HDV patients should be prioritized for new and potentially curative treatments.

LIVER INTERNATIONAL (2023)

Article Gastroenterology & Hepatology

Impact of potent nucleos(t)ide therapy on hepatitis B hospitalisations in Spain

Jose-Manuel Ramos-Rincon, Hector Pinargote-Celorio, Carmen de Mendoza, Clara Ramos-Belinchon, Pablo Barreiro, Ana Trevino, Octavio Corral, Vicente Soriano

Summary: Hospital admissions of individuals with HBV infection are increasing in Spain, and while hepatic decompensation events have declined, HBV-related liver cancer continues to rise. Oral antiviral therapies do not have any benefit on hepatitis delta.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2023)

Article Medicine, General & Internal

Predictors of in-hospital mortality in HIV-infected patients with COVID-19

Victor Moreno-Torres, Carmen de Mendoza, Maria Martinez-Urbistondo, Patricia Mills, Ana Trevino, Sara de la Fuente, Alberto Diaz de Santiago, Jorge Calderon-Parra, Ilduara Pintos-Pascual, Manuel Corpas, Vicente Soriano

Summary: HIV-infected patients hospitalized in Spain with COVID-19 during 2020 had lower mortality rate compared to HIV-negatives, likely due to younger age and lower rate of comorbidities. However, advanced liver disease was a major predictor of death in HIV-infected patients hospitalized with COVID-19.

QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2023)

Review Chemistry, Medicinal

Bulevirtide in the Treatment of Hepatitis Delta: Drug Discovery, Clinical Development and Place in Therapy

Vicente Soriano, Victor Moreno-Torres, Ana Trevino, Octavio Corral, Carmen de Mendoza

Summary: It has been ten years since the identification of NTCP as the cell surface receptor for HBV and HDV entry into hepatocytes. Bulevirtide (BLV) has been developed as a potential inhibitor of NTCP-HBV/HDV binding and has shown promising results in preclinical and clinical studies. Combination therapies with BLV and other anti-HBV/HDV agents are expected to lead to a cure for hepatitis delta in the near future.

DRUG DESIGN DEVELOPMENT AND THERAPY (2023)

Review Endocrinology & Metabolism

Molecular basis of normal and pathological puberty: from basic mechanisms to clinical implications

Jesus Argente, Leo Dunkel, Ursula B. Kaiser, Ana C. Latronico, Alejandro Lomniczi, Leandro Soriano-Guillen, Manuel Tena-Sempere

Summary: Puberty, a major maturational event, is determined by genetic factors and influenced by endogenous and environmental cues. Research progress has been made in understanding the neuroendocrine networks governing puberty, but the precise timing and mechanisms of puberty and its alterations are still being deciphered. This review provides a comprehensive overview of the physiological basis of puberty, including the roles of kisspeptins and other central transmitters, the underlying molecular and endocrine mechanisms, and the pathways involved in pubertal modulation. Molecular features of precocious and delayed puberty are also summarized. The review highlights the need for further research in this active field of endocrinology.

LANCET DIABETES & ENDOCRINOLOGY (2023)

Review Immunology

Viral hepatitis in persons living with HIV in the post-COVID era

Vicente Soriano, Victor Moreno-Torres, Carmen De Mendoza, Octavio Corral, Pablo Barreiro

Summary: Coinfection with hepatitis viruses A to E is frequent and causes significant morbidity and mortality in persons living with HIV (PLWH). Hepatitis A and E mainly produce acute self-limited episodes in poor income regions and non-vaccinated travelers. Chronic hepatitis B, C, and D are frequent in PLWH in highly endemic regions and globally in persons who inject drugs and men having sex with men. Rating: 8 out of 10.

AIDS REVIEWS (2023)

News Item Immunology

Coinfection with Viral Hepatitis in HIV patients in 2023

Pablo Barreiro, Victor Moreno-Torres, Vicente Soriano

AIDS REVIEWS (2023)

Article Immunology

Increased incidence of giant cell arteritis and associated stroke during the COVID-19 pandemic in Spain: A nation-wide population study

Victor Moreno-Torres, Vicente Soriano, Jorge Calderon-Parra, Maria Martinez-Urbistondo, Ana Trevino, Zayrho de San Vicente, Carmen de Mendoza, Guillermo Ruiz-Irastorza

Summary: A retrospective nationwide observational analysis in Spain found an increased incidence of giant-cell arteritis (GCA) and associated stroke after SARS-CoV-2 infection and COVID-19 vaccination. The study compared hospital admissions for GCA between pre-pandemic (2016-2019) and pandemic (2020-2021) years. The incidence of GCA and GCA-associated stroke was higher during the pandemic years, particularly during the third wave of COVID-19 and the third dose vaccination in patients older than 70. The findings suggest a potential link between COVID-19 and mRNA-SARS-CoV-2 vaccines with an increased risk of GCA and stroke.

AUTOIMMUNITY REVIEWS (2023)

Review Pharmacology & Pharmacy

Safety considerations in the management of hepatitis C and HIV co-infection

Vicente Soriano, Victor Moreno-Torres, Ana Trevino, Pablo Barreiro, Fernando de Jesus, Octavio Corral, Carmen de Mendoza

Summary: HCV and HIV are highly prevalent infections worldwide. Oral antivirals can cure HCV and slow down disease progression in HIV patients. However, dual therapy for HCV and HIV presents challenges such as drug-related side effects, hepatitis B reactivation, immune reconstitution inflammatory syndromes (IRIS), and drug-drug interactions (DDI).

EXPERT OPINION ON DRUG SAFETY (2023)

Letter Medicine, General & Internal

Response to: Prognostic factors in hospitalized HIV-positive patients with COVID-19: correspondence

V Moreno-Torres, V Soriano

QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2023)

Article Gastroenterology & Hepatology

Triple Threat: HDV, HBV, HIV Coinfection

Debra W. Yen, Vicente Soriano, Pablo Barreiro, Kenneth E. Sherman

CLINICS IN LIVER DISEASE (2023)

Article Multidisciplinary Sciences

Genetic signature detected in T cell receptors from patients with severe COVID-19

Manuel Corpas, Carmen de Mendoza, Victor Moreno-Torres, Ilduara Pintos, Pedro Seoane, James R. Perkins, Juan A. G. Ranea, Segun Fatumo, Tamas Korcsmaros, Jose Manuel Martin-Villa, Pablo Barreiro, Octavio Corral, Vicente Soriano

Summary: Characterization of host genetic factors contributing to COVID-19 severity reveals a possible role of T cell response dysfunction, as indicated by the identification of variants in the T cell receptor beta locus associated with severe COVID-19.

ISCIENCE (2023)

Article Medical Ethics

Current Challenges for Conscientious Objection by Physicians in Spain

Vicente Soriano, Borja Montero

Summary: The College of Physicians of Madrid organized a debate on conscientious objection in the medical profession. The main arguments discussed centered around the definition of conscientious objection, the importance of medical ethics, and the potential harm of suppressing the ethical dimension of medical care. The debate also touched on the recent Spanish laws on abortion, euthanasia, and sex re-assignment of minors, highlighting the need to respect the freedom of physicians to refuse actions that go against their ethical values.

LINACRE QUARTERLY (2023)

Article Immunology

HTLV infection in persons with sexually transmitted diseases in Spain

Oskar Ayerdi, Rafael Benito, Diego Ortega, Antonio Aguilera, Natalia Montiel, Ilduara Pintos, Alberto Diaz de Santiago, Begona Baza, Vicente Soriano, Carmen de Mendoza

Summary: The prevalence of HTLV infection among individuals with STIs in Spain is 0.5%, higher than in the general population. These results suggest the need for universal HTLV screening in individuals attending clinics for STIs.

FRONTIERS IN IMMUNOLOGY (2023)

Article Virology

HTLV-1-associated myelopathy in Spain

Carmen de-Mendoza, Leire Perez, Ariadna Rando, Gabriel Reina, Antonio Aguilera, Rafael Benito, Jose Maria Eiros, Itziar Rodriguez-Avial, Diego Ortega, Maria Jose Pozuelo, Maria Jose Pena, Vicente Soriano

Summary: HAM is the most common clinical manifestation of HTLV-1 infection in Spain, and it mainly affects middle-aged women migrants from Latin America. Despite the use of antiretroviral therapy, two thirds of HAM patients end up in a wheelchair.

JOURNAL OF CLINICAL VIROLOGY (2023)

No Data Available